Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics*
Linn Fagerberg, B. Hallström, P. Oksvold, et al.. (2013). Molecular & Cellular Proteomics. Cited 2,394 times. https://doi.org/10.1074/mcp.M113.035600Genic insights from integrated human proteomics in GeneCards
Simon Fishilevich, Shahar Zimmerman, Asher Kohn, et al.. (2016). Database: The Journal of Biological Databases and Curation. Cited 173 times. https://doi.org/10.1093/database/baw030Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.
S. Miskinyte, M. G. Butler, D. Hervé, et al.. (2011). American journal of human genetics. Cited 117 times. https://doi.org/10.1016/j.ajhg.2011.04.017Novel severe hemophilia A and moyamoya (SHAM) syndrome caused by Xq28 deletions encompassing F8 and BRCC3 genes.
S. Janczar, A. Fogtman, Marta Koblowska, et al.. (2014). Blood. Cited 31 times. https://doi.org/10.1182/blood-2014-02-553685The 8 kD product of the putative oncogene MTCP-1 is a mitochondrial protein.
A. Madani, J. Soulier, M. Schmid, et al.. (1995). Oncogene. Cited 26 times.A possible mechanism for Inv22‐related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors
J. Fujita, Yuhri Miyawaki, Atsuo Suzuki, et al.. (2012). Journal of Thrombosis and Haemostasis. Cited 23 times. https://doi.org/10.1111/j.1538-7836.2012.04897.xX‐linked moyamoya syndrome associated with severe haemophilia A
M. Lavin, P. Jenkins, C. Keenan, et al.. (2016). Haemophilia. Cited 10 times. https://doi.org/10.1111/hae.12806miR-126 Suppresses Invasion and Migration of Malignant Glioma by Targeting Mature T Cell Proliferation 1 (MTCP1)
Liangbo Han, Huaqiang Liu, Jinfeng Wu, et al.. (2018). Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. Cited 7 times. https://doi.org/10.12659/MSM.910292